![Jayson Punwani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jayson Punwani
Directeur/Membre du Conseil chez
ArmaGen, Inc.
Profil
Jayson Punwani is the founder of Coho Therapeutics, Inc., founded in 2019.
Current jobs include Director at ArmaGen, Inc., Director at Palleon Pharmaceuticals, Inc., Director at Xilio Therapeutics LLC since 2020, and Managing Director at Abingworth LLP.
Former jobs include Director at Xilio Therapeutics, Inc., Director at StrideBio, Inc., Director at VelosBio, Inc., Principal at Pappas Capital LLC from 2011 to 2017, and Partner at Takeda Ventures, Inc. from 2017 to 2020.
Education includes a doctorate from the University of Utah, an undergraduate degree from The College of New Jersey, and an MBA from The University of North Carolina at Charlotte.
Postes actifs de Jayson Punwani
| Sociétés | Poste | Début |
|---|---|---|
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Directeur/Membre du Conseil | - |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Directeur/Membre du Conseil | - |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Directeur/Membre du Conseil | 02/03/2020 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Private Equity Investor | - |
Anciens postes connus de Jayson Punwani
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Private Equity Investor | 01/11/2020 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Analyste en capital-investissement | 31/10/2017 |
Coho Therapeutics, Inc.
 Coho Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceuticals | Fondateur | - |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Directeur/Membre du Conseil | - |
| XILIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Jayson Punwani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Coho Therapeutics, Inc.
Coho Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceuticals | Health Technology |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Health Technology |
